Haemophilia A Treatment — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Factor VIII concentrate replacement
Severe haemophilia A (<1% FVIII): acute bleeds are treated with factor VIII concentrate replacement. Target FVIII level for joint bleeds is 40-60%. Desmopressin is useful in mild haemophilia A only (it releases stored FVIII from endothelial cells). Regular prophylactic FVIII infusions prevent joint damage. Emicizumab is an alternative prophylactic agent.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: Haemophilia